In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) ...

Peter DeYoung, CEO at Piramal Pharma Limited, explains how Piramal is meeting the growing demand for integrated biologics ...

Pharmaceutical Technology® spoke with Martin Meeson, CEO of Axplora, about the role contract development and manufacturing ...

Teva’s investigational monoclonal antibody, TEV-53408, has been designed for use in adults with celiac disease, for which a ...

Both companies viewed the early end to the PIVOT-PO trial as a positive development, with GSK saying it would work with US ...